Exercise OPT year 3. Roche reagents
Ended Awarded Last action
- Contract number
- 36C24925N0397
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $54,465
Award facts
- Contract value 100% obligated
- $54,465.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$37,270 | |
| Original award | $91,735 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 9, awarded a $54,465.42 delivery order to Roche Diagnostics Corporation for the exercise of option year 3 related to Roche reagents. This delivery order falls under a firm fixed-price contract structure with no set-aside designation and is scheduled for completion by October 31, 2025. The award was issued on February 28, 2025, with performance taking place at Roche Diagnostics' facility in Castleton, Indiana. As a child contract, this delivery order likely derives from a larger indefinite delivery vehicle or blanket purchase agreement established through the General Services Administration schedule, such as the In Vitro Diagnostics, Reagents, Test schedule, which enables the VA to efficiently procure pre-negotiated diagnostic reagent supplies.
Roche Diagnostics Corporation is a global leader in in vitro diagnostic solutions and laboratory instruments that support federal healthcare delivery systems across the Department of Veterans Affairs and other civilian agencies. The company supplies a comprehensive portfolio of laboratory reagents, testing equipment, and diagnostic technologies supporting disease detection, patient care, and medical research. The reagent products provided under this delivery order support critical laboratory testing functions across the VA healthcare network, consistent with Roche Diagnostics' longstanding role as a primary supplier of molecular diagnostic testing, clinical chemistry, and specialized reagents to support veterans' healthcare needs.
Quick answers
Who was awarded contract 36C24925N0397?
36C24925N0397 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 9 (Veterans Health Administration) on February 28, 2025.
How much is contract 36C24925N0397 worth?
The government has obligated $54,465 on 36C24925N0397.
Is contract 36C24925N0397 an order under another contract?
Yes. 36C24925N0397 is a delivery order under 36C24922D0003, an indefinite delivery contract.
Was contract 36C24925N0397 competed?
The extent of competition for 36C24925N0397 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award